Results 31 to 40 of about 157 (113)

A novel radioiodination reagent for protein radiopharmaceuticals with L- lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis

open access: yesA novel radioiodination reagent for protein radiopharmaceuticals with L- lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis
Radiochemical design of polypeptides using metabolizable linkages would be attractive to enhance target-selective localization of radioactivity for diagnostic and therapeutic nuclear medicine. However, while use of ester bonds as the linkage allows selective release of the designed radiometabolite from covalently conjugated polypeptide after lysosomal ...
openaire  

Experimental Evaluation of Proposed Small-Molecule Inhibitors of Water Channel Aquaporin-1. [PDF]

open access: yesMol Pharmacol, 2016
Esteva-Font C   +5 more
europepmc   +1 more source

Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. [PDF]

open access: yesClin J Am Soc Nephrol, 2011
Meijer E   +6 more
europepmc   +1 more source

TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT. [PDF]

open access: yesACS Med Chem Lett, 2011
Chen Y   +5 more
europepmc   +1 more source

Renal 131I-hippuran extraction in man: effects of dopamine. [PDF]

open access: yesBr J Clin Pharmacol, 2002
Hutchings M   +3 more
europepmc   +1 more source

Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM). [PDF]

open access: yesBioorg Med Chem, 2008
Merkler DJ   +19 more
europepmc   +1 more source

Copper and its complexes in medicine: a biochemical approach. [PDF]

open access: yesMol Biol Int, 2011
Iakovidis I, Delimaris I, Piperakis SM.
europepmc   +1 more source

Home - About - Disclaimer - Privacy